477 related articles for article (PubMed ID: 30218633)
41. Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison.
Cannella R; Brancatelli G; Rangaswamy B; Minervini MI; Borhani AA; Furlan A
Eur J Radiol; 2019 Oct; 119():108633. PubMed ID: 31437747
[TBL] [Abstract][Full Text] [Related]
42. Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images.
Yoneda N; Matsui O; Kitao A; Kita R; Kozaka K; Koda W; Kobayashi S; Gabata T; Ikeda H; Sato Y; Nakanuma Y
Jpn J Radiol; 2012 Jul; 30(6):499-508. PubMed ID: 22618456
[TBL] [Abstract][Full Text] [Related]
43. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
44. Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors.
Gu K; Jeon TY; Yoo SY; Kim JH
Eur Radiol; 2021 Jan; 31(1):283-291. PubMed ID: 32797310
[TBL] [Abstract][Full Text] [Related]
45. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
[TBL] [Abstract][Full Text] [Related]
46. [Focal nodular hyperplasia and hepatocellular adenoma].
Bastati-Huber N; Pötter-Lang S; Ba-Ssalamah A
Radiologe; 2015 Jan; 55(1):18-26. PubMed ID: 25575723
[TBL] [Abstract][Full Text] [Related]
47. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.
Kitao A; Zen Y; Matsui O; Gabata T; Kobayashi S; Koda W; Kozaka K; Yoneda N; Yamashita T; Kaneko S; Nakanuma Y
Radiology; 2010 Sep; 256(3):817-26. PubMed ID: 20663969
[TBL] [Abstract][Full Text] [Related]
48. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
[TBL] [Abstract][Full Text] [Related]
49. Primovist, Eovist: what to expect?
Van Beers BE; Pastor CM; Hussain HK
J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332
[TBL] [Abstract][Full Text] [Related]
50. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
Ohama H; Imai Y; Nakashima O; Kogita S; Takamura M; Hori M; Seki Y; Sawai Y; Igura T; Fukuda K; Makino Y; Morimoto O; Ohsawa M; Sakamoto M; Murakami T
J Gastroenterol; 2014 Jun; 49(6):1081-93. PubMed ID: 23903870
[TBL] [Abstract][Full Text] [Related]
51. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma.
van den Esschert JW; van Gulik TM; Phoa SS
Dig Surg; 2010; 27(1):46-55. PubMed ID: 20357451
[TBL] [Abstract][Full Text] [Related]
52. Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging.
Ba-Ssalamah A; Antunes C; Feier D; Bastati N; Hodge JC; Stift J; Cipriano MA; Wrba F; Trauner M; Herold CJ; Caseiro-Alves F
Radiology; 2015 Oct; 277(1):104-13. PubMed ID: 25985059
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma.
Nishie A; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Ushijima Y; Takayama Y; Shirabe K; Fujita N; Kubo Y; Hirakawa M; Honda H
J Gastroenterol Hepatol; 2014 Mar; 29(3):561-7. PubMed ID: 24219648
[TBL] [Abstract][Full Text] [Related]
54. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver.
Vander Borght S; Libbrecht L; Blokzijl H; Faber KN; Moshage H; Aerts R; Van Steenbergen W; Jansen PL; Desmet VJ; Roskams TA
J Pathol; 2005 Dec; 207(4):471-82. PubMed ID: 16161006
[TBL] [Abstract][Full Text] [Related]
56. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.
Inoue T; Kudo M; Komuta M; Hayaishi S; Ueda T; Takita M; Kitai S; Hatanaka K; Yada N; Hagiwara S; Chung H; Sakurai T; Ueshima K; Sakamoto M; Maenishi O; Hyodo T; Okada M; Kumano S; Murakami T
J Gastroenterol; 2012 Sep; 47(9):1036-47. PubMed ID: 22526270
[TBL] [Abstract][Full Text] [Related]
57. [Differentiation between hyperintense hepatocellular carcinoma and focal nodular hyperplasia in hepatobiliary phase with multimodal parameters of magnetic resonance imaging].
Lang Y; Ma CQ; Deng LW; Wang J; Liu C; Xiao SL; Deng J; Li Q; Liu WW; Yang DS; Li XM
Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1069-1073. PubMed ID: 36727231
[No Abstract] [Full Text] [Related]
58. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
[TBL] [Abstract][Full Text] [Related]
59. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
[TBL] [Abstract][Full Text] [Related]
60. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
Alamri TM; Cerny M; Al Shaikh M; Billiard JS; Olivié D; Chagnon M; Tang A
Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]